Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Satoshi Shoji

Showing results (1-10 of 109) with videos related to

Pageof 11
Sort By:
Heart Failure Reviews|July 1, 2024
Beyond quadruple therapy: the potential roles for ivabradine, vericiguat, and omecamtiv mecarbil in the therapeutic armamentariumSatoshi Shoji, Robert J Mentz
British Journal of Clinical Pharmacology|May 19, 2018
Pharmacokinetics and C-reactive protein modelling of anti-interleukin-6 antibody (PF-04236921) in healthy volunteers and patients with autoimmune diseaseCheryl Li, Satoshi Shoji, Jean Beebe
Tanpakushitsu Kakusan Koso. Protein, Nucleic Acid, Enzyme|February 24, 2004
[Cerebellar circuit development and gene expression]Akira Sato, Satoshi Shoji, Teiichi Furuichi
Antimicrobial Agents and Chemotherapy|March 25, 2015
Population pharmacokinetic analysis of voriconazole from a pharmacokinetic study with immunocompromised Japanese pediatric subjectsChieko Muto, Satoshi Shoji, Yoshiro Tomono, et al.
Circulation. Heart Failure|August 13, 2025
Simultaneous or Rapid Sequence Optimization of Medical Therapy for Heart Failure: Time to Keep ScoreSatoshi Shoji, Gregg C Fonarow, Stephen J Greene
The Medical Clinics of North America|October 24, 2025
Optimal Diuretic Strategies for Chronic Heart FailureSatoshi Shoji, Martin Osorio Nader, Robert J Mentz
Journal of Clinical Pharmacology|September 13, 2019
Model-Based Comparison of Dose-Response Profiles of Tofacitinib in Japanese Versus Western Rheumatoid Arthritis PatientsMisaki Suzuki, Satoshi Shoji, So Miyoshi, et al.
Heart Failure Reviews|August 26, 2024
Embracing an era of targeted combination therapy for heart failure with preserved ejection fractionSatoshi Shoji, Stephen J Greene, Robert J Mentz
Translational Lung Cancer Research|January 13, 2023
Three non-small cell lung cancer patients who developed pulmonary thromboses during osimertinib treatment and could safely resume concomitant anticoagulation treatment: a report of three casesSatoshi Shoji, Satoshi Watanabe, Yusuke Hanazawa, et al.
British Journal of Clinical Pharmacology|October 10, 2013
Population pharmacokinetics of ampicillin and sulbactam in patients with community-acquired pneumonia: evaluation of the impact of renal impairmentElena Soto, Satoshi Shoji, Chieko Muto, et al.
Pageof 11

Showing results (1-10 of 109) with videos related to

Sort By:
Pageof 11
Heart Failure Reviews|July 1, 2024
Beyond quadruple therapy: the potential roles for ivabradine, vericiguat, and omecamtiv mecarbil in the therapeutic armamentariumSatoshi Shoji, Robert J Mentz
British Journal of Clinical Pharmacology|May 19, 2018
Pharmacokinetics and C-reactive protein modelling of anti-interleukin-6 antibody (PF-04236921) in healthy volunteers and patients with autoimmune diseaseCheryl Li, Satoshi Shoji, Jean Beebe
Tanpakushitsu Kakusan Koso. Protein, Nucleic Acid, Enzyme|February 24, 2004
[Cerebellar circuit development and gene expression]Akira Sato, Satoshi Shoji, Teiichi Furuichi
Antimicrobial Agents and Chemotherapy|March 25, 2015
Population pharmacokinetic analysis of voriconazole from a pharmacokinetic study with immunocompromised Japanese pediatric subjectsChieko Muto, Satoshi Shoji, Yoshiro Tomono, et al.
Circulation. Heart Failure|August 13, 2025
Simultaneous or Rapid Sequence Optimization of Medical Therapy for Heart Failure: Time to Keep ScoreSatoshi Shoji, Gregg C Fonarow, Stephen J Greene
The Medical Clinics of North America|October 24, 2025
Optimal Diuretic Strategies for Chronic Heart FailureSatoshi Shoji, Martin Osorio Nader, Robert J Mentz
Journal of Clinical Pharmacology|September 13, 2019
Model-Based Comparison of Dose-Response Profiles of Tofacitinib in Japanese Versus Western Rheumatoid Arthritis PatientsMisaki Suzuki, Satoshi Shoji, So Miyoshi, et al.
Heart Failure Reviews|August 26, 2024
Embracing an era of targeted combination therapy for heart failure with preserved ejection fractionSatoshi Shoji, Stephen J Greene, Robert J Mentz
Translational Lung Cancer Research|January 13, 2023
Three non-small cell lung cancer patients who developed pulmonary thromboses during osimertinib treatment and could safely resume concomitant anticoagulation treatment: a report of three casesSatoshi Shoji, Satoshi Watanabe, Yusuke Hanazawa, et al.
British Journal of Clinical Pharmacology|October 10, 2013
Population pharmacokinetics of ampicillin and sulbactam in patients with community-acquired pneumonia: evaluation of the impact of renal impairmentElena Soto, Satoshi Shoji, Chieko Muto, et al.
Pageof 11